carvedilol and dihydropyridines

carvedilol has been researched along with dihydropyridines in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (28.57)	18.2507
2000's	2 (28.57)	29.6817
2010's	2 (28.57)	24.3611
2020's	1 (14.29)	2.80

Authors

Authors	Studies
Feuerstein, G; Lysko, KA; Lysko, PG; Mason, PE; Mason, RP; Walter, MF; Webb, CL	1
Donckier, J; Godfraind, T; Heyndrickx, GR; Kyselovic, J; Massart, PE; Wibo, M	1
Catena, C; Donnini, D; Milocco, C; Moretti, M; Sechi, LA; Soardo, G	1
Beyenik, H; Dogan, E; Erkoc, R; Sayarlioglu, H; Topal, C	1
Barbosa, L; Bertoquini, S; Polónia, J; Silva, JA	1
Balthazar Nardotto, GH; Barbosa Coelho, E; Dantas, M; Hanauer Schaab, E; Lanchote, VL; Marques Pereira, MP; Paiva, CE	1
Hall, SD; Mohutsky, MA; Posada, MM; Taylor, LS; Tres, F	1

Trials

1 trial(s) available for carvedilol and dihydropyridines

Article	Year
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease. Journal of clinical pharmacology, 2020, Volume: 60, Issue:1 Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Stereoisomerism	2020

Article

Year

Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.

Journal of clinical pharmacology, 2020, Volume: 60, Issue:1

Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Stereoisomerism

2020

Other Studies

6 other study(ies) available for carvedilol and dihydropyridines

Article	Year
Neuroprotective activities of carvedilol and a hydroxylated derivative: role of membrane biophysical interactions. Biochemical pharmacology, 1998, Dec-15, Volume: 56, Issue:12 Topics: Animals; Antioxidants; Calcium Channel Blockers; Carbazoles; Carvedilol; Cell Membrane; Cells, Cultured; Cerebellum; Dihydropyridines; Free Radical Scavengers; Lipid Bilayers; Models, Molecular; Neurons; Neuroprotective Agents; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sodium Channel Blockers; Veratridine; X-Ray Diffraction	1998
Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding. Hypertension (Dallas, Tex. : 1979), 1999, Volume: 34, Issue:6 Topics: Actins; Animals; Antihypertensive Agents; Aortic Diseases; Blood Pressure; Carbazoles; Carotid Arteries; Carvedilol; Constriction, Pathologic; Dihydropyridines; Disease Models, Animal; Endothelin-1; Endothelins; Gene Expression; Heart Rate; Heart Ventricles; Hypertrophy, Left Ventricular; Labetalol; Ligation; Male; Myocardium; Organ Size; Propanolamines; Protein Precursors; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger	1999
Effects of antihypertensive drugs on alcohol-induced functional responses of cultured human endothelial cells. Hypertension research : official journal of the Japanese Society of Hypertension, 2008, Volume: 31, Issue:2 Topics: Antihypertensive Agents; Captopril; Carbazoles; Carvedilol; Cells, Cultured; Dihydropyridines; Dose-Response Relationship, Drug; Endothelial Cells; Ethanol; Humans; Malondialdehyde; Nitric Oxide; Oxidative Stress; Propanolamines	2008
Comparative effects of carvedilol and lercanidipine on ultrafiltration and solute transport in CAPD patients. Renal failure, 2009, Volume: 31, Issue:6 Topics: Adrenergic beta-Antagonists; Adult; Calcium Channel Blockers; Carbazoles; Carvedilol; Dihydropyridines; Female; Humans; Male; Middle Aged; Peritoneal Dialysis, Continuous Ambulatory; Peritoneum; Propanolamines; Ultrafiltration	2009
Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers. Blood pressure monitoring, 2010, Volume: 15, Issue:5 Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Aorta; Atenolol; Benzopyrans; Blood Flow Velocity; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Carbazoles; Carvedilol; Dihydropyridines; Diuretics; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Nebivolol; Propanolamines; Pulsatile Flow; Retrospective Studies; Vascular Resistance; Vasodilator Agents	2010
The Effect of Promiscuous Aggregation on in Vitro Drug Metabolism Assays. Pharmaceutical research, 2019, Oct-25, Volume: 36, Issue:12 Topics: Carvedilol; Colloids; Cytochrome P-450 Enzyme System; Diclofenac; Dihydropyridines; Drug Interactions; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Kinetics; Metabolic Clearance Rate; Microsomes, Liver; Phenacetin; Recombinant Proteins; Solvents; Tamoxifen	2019